These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 25378607)
21. The formation of P particle increased immunogenicity of norovirus P protein. Tan M; Jiang X Immunology; 2012 May; 136(1):28-9. PubMed ID: 22257239 [TBL] [Abstract][Full Text] [Related]
24. Human norovirus culture in B cells. Jones MK; Grau KR; Costantini V; Kolawole AO; de Graaf M; Freiden P; Graves CL; Koopmans M; Wallet SM; Tibbetts SA; Schultz-Cherry S; Wobus CE; Vinjé J; Karst SM Nat Protoc; 2015 Dec; 10(12):1939-47. PubMed ID: 26513671 [TBL] [Abstract][Full Text] [Related]
25. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? Ramani S; Estes MK; Atmar RL PLoS Pathog; 2016 Apr; 12(4):e1005334. PubMed ID: 27115358 [No Abstract] [Full Text] [Related]
26. Targeted Profiling of Immunological Genes during Norovirus Replication in Human Intestinal Enteroids. Chan JCM; Mohammad KN; Zhang LY; Wong SH; Chan MC Viruses; 2021 Jan; 13(2):. PubMed ID: 33494515 [TBL] [Abstract][Full Text] [Related]
27. Regulation of Norovirus Virulence by the VP1 Protruding Domain Correlates with B Cell Infection Efficiency. Zhu S; Watanabe M; Kirkpatrick E; Murray AB; Sok R; Karst SM J Virol; 2015 Dec; 90(6):2858-67. PubMed ID: 26719276 [TBL] [Abstract][Full Text] [Related]
28. Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican children. Long KZ; Garcia C; Ko G; Santos JI; Al Mamun A; Rosado JL; DuPont HL; Nathakumar N J Nutr; 2011 May; 141(5):957-63. PubMed ID: 21411606 [TBL] [Abstract][Full Text] [Related]
29. Differentiation and Protective Capacity of Virus-Specific CD8 Tomov VT; Palko O; Lau CW; Pattekar A; Sun Y; Tacheva R; Bengsch B; Manne S; Cosma GL; Eisenlohr LC; Nice TJ; Virgin HW; Wherry EJ Immunity; 2017 Oct; 47(4):723-738.e5. PubMed ID: 29031786 [TBL] [Abstract][Full Text] [Related]
30. Use of rabbit antibodies raised against Kulkarni R; Lole K; Chitambar SD Indian J Med Res; 2017 Dec; 146(6):788-790. PubMed ID: 29664039 [No Abstract] [Full Text] [Related]
31. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Donaldson EF; Lindesmith LC; Lobue AD; Baric RS Immunol Rev; 2008 Oct; 225():190-211. PubMed ID: 18837783 [TBL] [Abstract][Full Text] [Related]
32. Antibody is critical for the clearance of murine norovirus infection. Chachu KA; Strong DW; LoBue AD; Wobus CE; Baric RS; Virgin HW J Virol; 2008 Jul; 82(13):6610-7. PubMed ID: 18417579 [TBL] [Abstract][Full Text] [Related]
33. [Norovirus gastroenteritis: frequent, often epidemic, with potentially severe complications]. Kundig F; Chevalley P; Genné D Rev Med Suisse; 2013 Oct; 9(401):1806-8, 1810-1. PubMed ID: 24191413 [TBL] [Abstract][Full Text] [Related]
34. The evolution of norovirus, the "gastric flu". Lopman B; Zambon M; Brown DW PLoS Med; 2008 Feb; 5(2):e42. PubMed ID: 18271623 [TBL] [Abstract][Full Text] [Related]
37. Clinical profile of children with norovirus disease in rotavirus vaccine era. Wikswo ME; Desai R; Edwards KM; Staat MA; Szilagyi PG; Weinberg GA; Curns AT; Lopman B; Vinjé J; Parashar UD; Payne DC; Hall AJ Emerg Infect Dis; 2013 Oct; 19(10):1691-3. PubMed ID: 24047618 [No Abstract] [Full Text] [Related]
38. Noroviruses: a comprehensive review. Patel MM; Hall AJ; Vinjé J; Parashar UD J Clin Virol; 2009 Jan; 44(1):1-8. PubMed ID: 19084472 [No Abstract] [Full Text] [Related]
39. Norovirus gastroenteritis in immunocompromised patients. Bok K; Green KY N Engl J Med; 2012 Nov; 367(22):2126-32. PubMed ID: 23190223 [No Abstract] [Full Text] [Related]
40. Norovirus GII.4 antibodies in breast milk and serum samples: their role preventing virus-like particles binding to their receptors. Khodayar-Pardo P; Martínez-Costa C; Carmona-Vicente N; Buesa J Pediatr Infect Dis J; 2014 Jun; 33(6):554-9. PubMed ID: 24830517 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]